Markets:

Overview

News

Currencies

International

Treasuries

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of (NY:FMS)

24.01 -0.58 (-2.36%)

Official Closing Price Updated: 6:30 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of

< Previous 1 2 3 4 Next >

The Dialysis Renaissance: How DaVita (DVA) Conquered the GLP-1 Fear and Defined Healthcare Resilience in 2026

February 11, 2026

Date: February 11, 2026 Introduction In the first few weeks of 2026, a singular healthcare name has dominated the screens of institutional traders and retail investors alike: DaVita Inc. (NYSE: DVA)....

Via Finterra

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

This Fortinet Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday ↗

September 02, 2025

Via Benzinga

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum ↗

August 12, 2025

FDA approves Amphastar's iron sucrose injection for CKD-associated anemia, with potential for $80-100 million sales and a 2025 launch.

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

Dollar's Worst Start Since 1970s Could Dent European Corporate Profits ↗

August 05, 2025

Via Benzinga

Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 18, 2025

Via Benzinga

Topics Cannabis

Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency ↗

June 17, 2025

Fresenius Medical Care outlines new strategy with 5008X machine rollout in the U.S., launch of Value-Based Care segment, and cost-saving goals through FME25+.

Via Benzinga

5 Stocks To Ride The German Market Rally ↗

June 16, 2025

Via Benzinga

FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday ↗

May 06, 2025

Via Benzinga

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence ↗

April 22, 2025

Quest Diagnostics Q1 2025 revenue rose to $2.65 billion with EPS of $2.21, exceeding expectations; full-year guidance for sales and EPS reaffirmed.

Via Benzinga

Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday ↗

April 03, 2025

Via Benzinga

5 Classic Value Stocks For 2025 ↗

January 12, 2025

Alaska Air Group had a big year in 2024 as it closed on its deal for Hawaiian Airlines in September. It now flies to over 141 destinations.

Via Talk Markets

Topics Stocks / Equities

Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗

November 09, 2024

Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.

Via Benzinga

Topics Government

Current Analysis: Fresenius Medical Care (FMS) ↗

August 12, 2024

Fresenius Medical Care (FMS) is the largest dialysis company in the world. Over the past year, Fresenius's share price fell just over 30% from $26.09 to $18.14 as of Monday’s market close.

Via Talk Markets

Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 30, 2024

Via Benzinga

Stock Analysis: Fresenius Medical Care ↗

June 18, 2024

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022.

Via Talk Markets

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 30, 2024

Via Benzinga

Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway ↗

June 11, 2024

You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on.

Via InvestorPlace

Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers ↗

May 17, 2024

Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and...

Via Benzinga

Current Analysis: Fresenius Medical Care ↗

May 15, 2024

Fresenius Medical Care is the largest dialysis company in the world and a leading supplier of dialysis products, including machines, dialyzers, and concentrates.

Via Talk Markets

Topics Supply Chain

FMS Stock Earnings: Fresenius Medical Care Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

FMS stock results show that Fresenius Medical Care beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 07, 2024

Via Benzinga

AudioCodes Reports Downbeat Earnings, Joins Trupanion, Palantir Technologies And Other Big Stocks Moving Lower In Tuesday Pre-Market Session ↗

May 07, 2024

Via Benzinga

Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday ↗

April 22, 2024

Via Benzinga

Why Are Dialysis Provider Stocks Trading Higher On Tuesday? ↗

March 05, 2024

Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks

Via Benzinga

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday ↗

March 05, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

Via Benzinga

Topics Stocks

Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News ↗

March 05, 2024

Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.

Via Investor's Business Daily

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 05, 2024

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.